latest news on glp 1 drugs GLP-1 Drugs: 6 Things We've Learned About Their Effects As GLP-1 drugs go mainstream,

We will use this information as part of your personalized program plan

Conclusion PWS is a complex disorder, and this syndromic obesity predisposes to an early risk of developing several health conditions as cardiometabolic diseases

JAMA psychiatry , 82 (1), 9498

S.CognardC.DippelD.et al (2018)

Overall results were positive for both arms, with the PAP plus GLP-1 arm showing a 62.8% apnea-hypopnea index (AHI) reduction compared to a 55.0% AHI reduction from GLP-1 treatment alone

The intravenous route was chosen for administration of the parenteral control since this would ensure greatest reproducibility of entry into the bloodstream, and would match more closely the time course of entry of peptide from the intestine, which is seen to be rapid